The Four Things Drug Companies Don't Want You to Know

Image: Google Images

This is seriously riveting stuff.

Glaxo's Alli gets hammered by audience member. Glaxo declined to take part in an interview despite Alli being related to 13 cases of liver failure.

And listen to what the panel says about antidepressant drugs!

We're being duped people and our medicine regulators are playing the game along with the pharmaceutical industry.

I hear cries of "NO SHIT, SHERLOCK!"

Former pharmaceutical rep and author of Confessions of an Rx Drug Pusher, Gwen Olsen, also makes an appearance and tells the panel and audience how she, along with other reps "side-stepped the side effect profile of drugs to physicians."

Statins come under fire in Part II


The Four Things Drug Companies Don't Want You to Know

1. Drug companies underestimate dangerous side-effects.

2. Drug companies control much of the information your doctor gets about a drug.

3. You're often prescribed drugs you don't need.

4. Drugs target the symptom and not the cause.


Watch and learn.








Fid

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT [PAXIL] SCANDAL'
US/CANADA COPIES HERE OR UK/IRELAND FROM CHIPMUNKA PUBLISHING

Shadow falls over European drug regulator [EMA]

In my book, 'The evidence, however, is clear...the Seroxat scandal', I highlight the UK drugs regulator [MHRA] and their cosy relationship with GlaxoSmithKline and the rest of the pharmaceutical industry.

In fact, when I first started asking questions regarding the safety of Seroxat [Paxil in US] the MHRA's responses were less than transparent - it took Freedom of Information requests [FOI] for me to get some sort of answer from them, even then the answers were vague.


It appears that the European drugs regulator are pretty much the same, according to an article published in yesterday's Independent.

The EMA were sent FOI's from Professor Peter Gotzsche and Anders Jorgensen from the Danish Cochrane Centre, they wanted to investigate two obesity drugs, orlistat and sibutramine. They requested the unpublished trial data from the EMA in 2007.

The EMA refused access to the studies citing "commercial confidentiality" whilst defending their corner by arguing that they constantly monitored drugs and updated their assessments.

Orlistat is marketed as a prescription under the trade name Xenical by Roche in most countries, or over-the-counter as Alli [GlaxoSmithKline]

Quite a coincidence that GlaxoSmithKline recently announced that it is to sell off Alli and will, in the forthcoming weeks, be contacting parties interested in its product.

Sibutramine is better known by its brand name, Reductil, [Abbott] ironically suspended by the MHRA in January 2010 after the EMA informed them to suspend its licence in Europe amid fears that it raised the risk of heart attacks and strokes in patients taking it, this some three years after the request for the unpublished trial data was made by Professors Gotzsche and Jorgensen.

Eugene Sun, an Abbott spokesperson said at the time, "We believe there are many patients who benefit from sibutramine and respectfully disagree with the recommendation to suspend the medicine."

No surprise there then.

Gotzsche and Jorgensen, unhappy with the EMA's refusal to supply the unpublished trial data in 2007, wrote to the European ombudsman who, in 2010 [Yes, three years later] criticized the EMA's refusal to grant access to the trials and added that the EMA was guilty of maladministration.

Gotzsche and Jorgensen finally received the unpublished data in February 2011, some four years after they first requested it.

This is yet another example of the regulator protecting the pharmaceutical industry. To cite "commercial confidentiality" as an excuse to not release data is woeful, what about "consumer protection"?

I am not shocked any more by the regulators decisions, it appears that protecting the manufacturers is much higher on the agenda than protecting the consumer.

Further evidence of the collusion between the regulators and the pharmaceutical industry reared its ugly head back in June 2010 when I learned that the UK Seroxat litigation's defendants, GlaxoSmithKline, had hired the services of Rashmi Shah to be called as an expert witness for them. Shah was employed by the MHRA between 1987 and 2004.

I've met with various MHRA officials on numerous occasions. Their CEO, Kent Woods, gave up over an hour of his time to sit down with me and listen to my concerns regarding the difficulties patients were having withdrawing from SSRi medications. He even agreed that the MHRA should meet with Prof. David Healy, who had drawn up a withdrawal guidance to help patients withdraw from SSRi's. The meeting between Healy and the MHRA took place, Healy showed them the protocol... it still remains on the table collecting cobwebs!

More about the MHRA, GlaxoSmithKline and Seroxat in my book, which can be purchased online in the US and Canada HERE and in the UK HERE.

Fid

Former Glaxo Lawyer Files Motion & Glaxo Drug Down The Pan

Two stories from yesterday - one mentions the word 'motion', the other mentions Glaxo's wonder diet pill, Alli.

Play on words anybody?


Former Glaxo Lawyer Files Motion, Prepares to Open Defense

By Sue Reisinger

Lauren Stevens, the indicted former in-house lawyer for GlaxoSmithKline, asked a federal judge Monday to acquit her of six criminal charges that she obstructed a federal investigation and made false statements to investigators.

Stevens’s lawyers argued the point Monday after the government rested its case on May 6, and the defense filed a 37-page motion. Reid Weingarten, a partner at Steptoe & Johnson, leads the defense team.

The motion stated, “At the conclusion of the government’s case-in-chief, it has failed to present evidence sufficient to prove beyond a reasonable doubt any of the six counts against Ms. Stevens. For this reason, the Court should enter a judgment of acquittal.”

MORE HERE





GSK dumps weight-loss drug Alli

Reuters

GlaxoSmithKline is selling its weight-loss drug Alli, a product once seen as a key driver for its consumer healthcare division, as part of an overhaul of the non-prescription medicine unit.

Other over-the-counter products being divested include painkillers Solpadeine, BC and Goody's; vitamin and supplement product Abtei; and feminine hygiene treatment Lactacyd, Britain's biggest drugmaker said on Thursday.

MORE HERE


Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR FROM CHIPMUNKA PUBLISHING [UK]

GSK's ALLI - "Major health warning issued..."

The Daily Express reported yesterday [Mar 6, 2010] that there has been a major health warning issued regarding GlaxoSmithKline's diet pill. Alli.

They write that the evidence against Alli [generic name orlistat] appears to be growing.

The 31 adverse reactions include palpitations, tummy problems and swollen tongues.
Patients taking a common drug to treat thyroid problems are also being told to seek advice from a doctor because the medicines could interact badly.

Since diarrhoea is a common side-effect, women are warned it could lessen the effectiveness of the contraceptive Pill.

US health watchdogs are investigating links to liver disease, though European researchers disagree.

The UK’s drugs safety watchdog, the Medicines and Healthcare Regulatory Authority, is now insisting that new warnings are added to packets of Alli following a review by the EU Committee for Medicinal Products for Human Use.

Alli works by stopping the body from absorbing fat.

For every 2lb patients lose through diet and exercise, it can increase weight loss by another 1lb.

More from the Daily Express article HERE

You can read my rants about Alli and other related stories at the following links.


GSK's Alliconnect Blog Goes Down the Crapper!

FDA probes liver damage with Glaxo'sl Alli

GSK's Alli Linked to Liver Failure!

This size-8 girl was able to buy diet pills [Alli] at her local chemists

Alli pimping - GSK's new Ally

Diet drug Xenical renamed Alli, still a cancer worry

Angry Aussie slams Alli

GlaxoSmithKline Complaints Dept

Alli - The Poem

Experts wary of new diet pill

GSK - The Alli Spin

GSK 'Crossing the line with Alli

GSK's Alli and The Obesity Society

GSK's Alli

GlaxoSmithKline's 'Belly' laugh

Lose Weight with GSK's Alli...

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GSK's Alliconnect Blog Goes Down the Crapper!

With ever increasing concerns regarding it's 'Shit yourself thin' diet pill, Alli, GSK seems to have pulled the plug on Alliconnect, a blog initially set up to promote what was deemed to be the next best thing to sliced bread [un-buttered of course]

Despite the FDA issuing a statement back in August stating they were taking a closer look at GSK's Alli as they had received 32 reports of serious liver injury among patients taking it.

In typical Glaxo style, they issued a statement in defence of Alli later that month. Basically and unsurprisingly they confirmed that Alli was safe.

Alliconnect, the master-stroke of GSK seems to have disappeared off the face of the planet.

Back to the drawing board folks.

Here's a tip - Instead of focusing on the product, try focusing on those that take it!

Tead more about Alli HERE.

Here's a spoof video for it too.



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

FDA probes liver damage with Glaxo'sl Alli

August 24th [SOURCE]

The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.

Read more HERE




Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GSK's Alli Linked to Liver Failure!

Source: Sunday Mail
Hat-Tip - Ruth

A slimming pill that triggered massive sales when it was launched earlier this year is being investigated amid fears it is linked to liver damage.

Alli, which blocks the absorption of fat in the gut, is the first diet pill of its kind to be available without prescription.

Its main ingredient is the drug orlistat. But now the US medicine watchdog, the Food and Drug Administration (FDA), is investigating a series of alerts from patients who developed problems while taking orlistat.

The UK drugs regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has also received 31 reports of side effects linked to orlistat since Alli was launched in April.

But it was not able to say if those were from patients taking Alli or the stronger pill Xenical – which also contains orlistat but is available only on prescription.

Since Xenical became available in 2001, 24 patients taking it have died, one of liver failure and the others from heart attacks, gall bladder inflammation, multi-organ failure and lung clots. There were also five cases of sudden death where the cause was unclear. In total, the MHRA has received 1,252 reports from patients of potential side effects from Xenical, including heart problems, gastrointestinal issues and skin complaints. Nearly 100 were connected with liver problems.

On the day Alli was launched in the UK, £1million worth of pills were sold. But it has already provoked controversy. Manufacturer GlaxoSmithKline (GSK) claims it can boost weight loss by up to 50 per cent, helping dieters lose an extra 1lb for every 2lb shed.

Read More

Related Links:

This size-8 girl was able to buy diet pills [Alli] at her local chemists

Alli pimping - GSK's new Ally

Diet drug Xenical renamed Alli, still a cancer worry

Angry Aussie slams Alli

GlaxoSmithKline Complaints Dept

Alli - The Poem

Experts wary of new diet pill

GSK - The Alli Spin

GSK 'Crossing the line with Alli

GSK's Alli and The Obesity Society

GSK's Alli

GlaxoSmithKline's 'Belly' laugh

Lose Weight with GSK's Alli...

Fid


ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

This size-8 girl was able to buy diet pills [Alli] at her local chemists

Source: The Irish Independent

Irish chemists are selling a new 'over the counter' diet pill to healthy thin young girls -- despite reassurance by the drug's manufacturers that staff will only sell the drug to people who suffer from obesity.

An investigation carried out by The Sunday Independent has found that every chemist approached by the newspaper was happy to sell the 'miracle' new weight loss pill Alli to a size-eight woman.

This is despite the fact that the drugs makers GlaxoSmithKline have given reassurances that all pharmacists will be trained to calculate a person's Body Mass Index (BMI) -- which must be over 28) -- before selling the pill.

The shocking findings have left eating disorder support groups "deeply concerned" that the drug will now be open to widespread misuse.

At eight and a half stone, this reporter successfully purchased the tablets despite being well under the recommended 12 stone 5 pounds needed to meet the manufacturer's recommended guidelines.

In a straw poll of chemists in Dublin and Kildare, every one approached was willing to sell the drug.

Although the drug's makers have said chemists had been trained to weigh customers and ask them suitable "fielding" questions on their motivation for taking the drug -- The Sunday Independent uncovered an incredibly lax attitude towards its sale.

When asked for a packet of the tablets, a staff member at one high-profile chemist chain in Dublin's city centre area said: "You do know this is only for obese people?" before shaking her head, smiling, and ringing the product through the till.

While another chemist worker simply asked if it was "any good?" before taking it to the cash register.

A number of staff were also prepared to sell the diet pill even when the product was purchased alongside a packet of laxatives -- a substance well-known for its abuse among the dieting community.

One 22-year-old student who managed to purchase the tablets despite being a size eight described how she will be using the drug to help her with her bikini-diet.

"I've heard loads about the pill in glossy magazines and I'm so happy it's finally out. If it actually does what it promises to do and matches every two pounds I lose with another pound then I'll be thrilled," she enthused.

When contacted, a spokesperson for GlaxoSmithKline said they were "very surprised" to hear chemists were selling the drug to healthy young women.

"We have been rolling out a training programme for the past three months" he said. "The key thing we wanted to get across is that they cannot sell it to people with a BMI lower than 28. There is absolutely no wriggle room in that."

Hailed as a new wonder drug, Alli went on sale in Ireland amidst much hype last week.

It works by flushing out up to 25 per cent of the fat from all food consumed and forcing the undigested fat to pass straight through the body, creating what is described as "an urgent need to go to the bathroom".

Clinical trials show that Alli, when used in conjunction with a reduced calorie, lower-fat diet, can help people lose 50 per cent more weight than by dieting alone.

Users of the drug can lose 3lbs a week, according to its manufacturer GlaxoSmithKline, which equates to more than three stone over four months.

The recommended dose of Alli is one 60mg capsule three times a day with meals containing the recommended amount of fat (15 grams).

Speaking about the new drug, a spokesperson for Bodywhys said: "A high proportion of those affected by eating disorders misuse other medications such as laxatives and diuretics in an attempt to attain or maintain a low body weight. Our concern would be around ensuring that this new medication does not become a new mechanism for that purpose."

- NIAMH HORAN

Hat-Tip - Truthman

----
Fid

More about Glaxo's 'Alli'

Xenical/Alli - Can it cause heart attacks?

Alli pimping - GSK's new Ally

Diet drug Xenical renamed Alli, still a cancer worry

Angry Aussie slams Alli

GlaxoSmithKline Complaints Dept

Alli - The Poem

Experts wary of new diet pill

GSK - The Alli Spin

GSK 'Crossing the line with Alli

GSK's Alli and The Obesity Society

GSK's Alli

GlaxoSmithKline's 'Belly' laugh

Lose Weight with GSK's Alli...

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GSK Threatens Access to Weight Loss Supplements

Washington, DC - GlaxoSmithKline, the second-largest pharmaceutical company in the world, has threatened your access to supplements by petitioning the FDA to classify weight loss claims for dietary supplements as ‘disease claims’.

Washington, DC - On April 17th, 2008, pharmaceutical giant GlaxoSmithKline (GSK) submitted a Citizen Petition calling for the U.S. Food and Drug Administration (FDA) to reclassify all weight loss support claims for dietary supplements as disease claims. Read the full petition here.

Read full story at Citizens For Health

Fid

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GSK Petition Threatens Weight Loss Supplements

Source: Dietary Supplement Information Bureau

Dear Dietary Supplement Industry Member,

As you may know, GlaxoSmithKline (GSK) has petitioned the FDA to classify weight loss claims for dietary supplements as disease claims. Many people say that this is nothing more than an attempt by the makers of alli™, the first over-the-counter weight loss drug, to quash competition from the supplement weight loss industry. Some say it is yet another instance of a pharmaceutical giant using its considerable resources for legal and political advantages against competing products in the supplements industry, products which are safer and produce fewer side-effects, yet are often as or more effective than their pharmaceutical counterparts.

This may have huge implications for not only the supplement weight loss industry, which is rapidly growing and estimated to currently be worth $1.3 billion in annual sales, but for the dietary supplements industry overall; some see it as another step in the overregulation of dietary supplements and attacks from big pharma, which, should FDA decide to rule in favor of GSK, some say could be a death knell for our industry.

The industry is abuzz with regards to this petition; some feel that we should defend weight loss supplements as they are an important category of product for our industry and are being attacked unfairly by a company with a questionable record of honesty. As you may know, the FDA recently issued a warning to GlaxoSmithKline for not reporting safety results on its diabetes pill Avandia. Previously, the Senate Finance Committee found that Glaxo Smith Kline intimidated and coerced a prominent critic of Avandia so that he would no longer speak critically of the drug. Just before that, it was alleged that the company systematically hid and manipulated data concerning Paxil-induced suicide in depressed adults.

Others in our industry believe that misleading advertising related to this category of supplements has become so egregious that companies selling the supplements deserve whatever actions may take place against them.

As members of the industry, we’d like to hear your opinions. Please click on the link to comment below. We’ll keep you updated and let you know more about this and other critical issues.

Click here to read the full petition: PDF (3.2 MB)

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

By Bob Fiddaman

ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING

AVAILABLE FOR DOWNLOAD HERE


PAPERBACK COMING SOON

Xenical/Alli - Can it cause heart attacks?

Earlier this year I posted about Alli, GlaxoSmithKline's new wonder diet pill. Much has been said about Glaxo's new baby but one comment after my post caused me great concern, so much so that I will republish it here.

I believe this product caused me to have a heart attack.I started having unusual symptoms, not the kind described with their product. I started having extreme sleeplessness. Couldn't go to sleep even at midnight and then wide awake at 5 AM. A nauseated stomach, a pain where I didn't want to eat much or it would make me sick. Then two days before the heart attack I started bleeding rectally with BM. Two days later, I had a short period of extreme dizziness, then sat down and had a heart attack.

I do not have a history of any heart problems or arrythmia's. And the follow-up echocardiogram and angiogram could see no abnormalities. And I have not had these problems since I stopped taking the product.

Anyone else out there having similar complaints?

katwilo2

Alli pimping - GSK's new Ally

Not content with shit shovelling us diarrhoea from GSK headquarters regarding the 'shit yourself thin pill' Alli, Glaxo, it seems employed the services of Debbie Weil to pimp their product.

Who is Debbie Weil?

Well, she is the author of... wait for it.... The Corporate Blogging Book: Absolutely Everything You Need to Know to Get It Right

The link (above) takes you to Amazon where you can purchase copies of her masterpiece. She even offers the chance to win copies of her book by taking 'a quick survey'.

She adds:

"Lots of smart folks are saying that 2007 will be the year of executing -- as opposed to asking why or what -- when it comes to business blogs. And I agree with them. But I want to know what *you* are thinking."

Well, Debbie, I'm thinking that by pimping GlaxoSmithKline's Alli you have quite literally 'shat' yourself in the foot.

Now, if you want any advice on how to write a blog or indeed how to write a book about writing a blog then I suggest you skim through the archives of this blog and a host of others provided in the links section on this page.

Oh, and here's another tip for you while I'm at it - Give the money you received from GSK (if they paid you that is?) to a bowel charity.

I hereby award Debbie Weil with the Seroxat Sufferers prestigious Dumbass Award

Fid

Debbie Weil you are a dumbass!

Diet drug Xenical renamed Alli, still a cancer worry

Source: The Cancer Blog

Prescription weight-loss drug Xenical hit drugstore shelves on Friday with a new name -- Alli (pronounced: "Al-eye") and with a new non-prescription strength. The newly-named drug is to be more effective with less unpleasureable side effects. Still, there's a problem surrounding this drug, regardless of its name. It's thought to cause colon cancer

The nonprofit group Public Citizen says Alli, made by GlaxoSmithKline, has been shown in mice studies to cause pre-cancerous lesions in the colon. Since there are no long-term studies on humans, this group believes the FDA should not have approved the drug for non-prescription use. It's not clear whether or not the pre-cancerous spots will lead to colon cancer but the mere suggestion that it might is enough, says a Public Citizen spokesperson.

"What we do know is that these lesions occur much more frequently in people who do get colon cancer," he said. "Why do we recommend that everyone get a colonscopy at the age of 50? Because you pick up on these polyps when you do one. And, even though not all of the polyps are pre-cancerous, no (doctor) does a colonscopy without removing every single polyp that is found. And you do this because you know if you don't, it greatly increases the chances of getting cancer."

The FDA says there is not enough evidence to link Alli and colon cancer -- or breast cancer, another Public Citizen concern.

Huge weight gains reported by patients on prescription drugs

Source: The Independent

Thousands of people who take prescription medicines for everyday conditions are gaining large amounts of weight as an unexpected side effect, scientists have warned.

Researchers, who found that some patients were putting on up to 22lbs in a year, say that the drugs may even be contributing to the nation's rocketing obesity epidemic.

Full Story

Good news for Glaxo's 'Shit yourself thin pill' hey?

Every cloud... as they say

Bob

Angry Aussie slams Alli

Miracle diet pill! (with a teenty-tiny side effect)

You can read more of the Angry Aussie's rants here


alli

GlaxoSmithKline Gets Social

GSK has launched a blog authored by their very own Steve Burton, VP of weight control for GSK consumer healthcare. (He of 'We have gone out of our way to be honest fame').

The blog is entitled 'Alliconnect' not to be confused with the amusing http://alliconnect.wordpress.com/

It seems GSK are now jumping aboard the blog bandwagon to publicise their products so I would like to take this opportunity to welcome them and thank them for highlighting just how low they will stoop to launch a product.

Alliconnect even has a forum... now why haven't GSK created a Seroxat forum for worried patients? I mean they have had many years to do so!

Alas, it is left to the sufferers to bang the drum warning over the dangers.

Bob

MHRA's role in Alli?

So what was the role of the MHRA in passing GlaxoSmithKline's new shit pill Alli?


Surely they saw the clinical trial data this time or did GlaxoSmithKline just show them the positive results... as they always do when trying to launch a new product.


I'm fascinated by the name 'Alli' - Ironically it is pronounced 'A LIE' and not Ali, as in Muhammed Ali.


Personally, I think the GlaxoSmithKline marketing team dropped a huge bollock on this one. Maybe, Alli is a subliminal message or a piss-take to the general public, meaning 'We can produce shit drugs and still get away with it?


This table intrigues me:

Take a look at the adverse event section, Fecal Urgency.

22.1% of patients felt the need to take a dump whilst being 'under the influence' of Alli

6.7% of patients who NEVER took Alli (Placebo) also felt the need to take a rather large plop into the porcelain bowl.

What is the significance?

Are GlaxoSmithKline trying to weigh up the statistics with a natural urge here?

So some guy takes a sugar pill and thinks 'Hmmm, I know I may have took Alli and I know that it may cause me to poo... strangely, I feel like a poo now'

What are GlaxoSmithKline trying to say here?

Look, it clearly shows that people who took the sugar pill suffered with psychosomatic problems because they knew Alli caused the sensation of wanting a crap!

What utter bollocks!

Yet again, one of GlaxoSmithKline's drugs has slipped through those great minds at the MHRA.

Youtube and blogs are full of bad publicity for this drug - even rival pharmaceutical companies are making mock videos and posting them on youtube.

It's been a bad couple of months for GlaxoSmithKline what with the Avandia scandal and now this little shit popper called Alli...

...and I'm loving every minute of it

'TAKE MORE...SHIT LONGER'

alli

GlaxoSmithKline Complaints Dept

"We've done everything to go out of our way to be honest,"

Steven Burton, vice-president weight control division of GlaxoSmithKline

alli

Alli - The Poem

ALLI - The Poem

So Glaxo launched its Alli

a pill to make us thin.

It's full of hidden side-effects

so where do I begin?

First it causes bum juice

of the smelly kind.

Be careful not to break wind

in spaces so confined.

Your stomach will be churning

and bubbling all day long.

I recommend dark trousers

a diaper or sarong.

Glaxo's big blockbuster

is sure to be a hit.

A pill to help us lose weight,

and one to help us shit!

Consider exercising

to keep that weight gain down.

Forget the pill that turns your pants

into the colour chocolate brown.

© Bob Fiddaman 2007

alli

Man takes Alli and suffers side effects!!!

GSK - "Take More... Shit Longer"


alli